ArticleInvestigational new drugs2024
Targeting LEF1-mediated epithelial-mesenchymal transition reverses lenvatinib resistance in hepatocellular carcinoma.
Xinxiu Li et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it